Vijay Mohan | Cancer Drug Discovery | Innovative Research Award

Published-on by Indian Scientist

Innovative Research Award

Vijay Mohan
Galgotias University

Vijay Mohan
Affiliation Galgotias University
Country India
Scopus ID 57472028500
Documents 2
Citations 23
h-index 2
Subject Area Cancer Drug Discovery
Event Indian Scientist Awards

Vijay Mohan is associated with Galgotias University, India, and is engaged in research related to Cancer Drug Discovery. His academic work focuses on scientific approaches that contribute to understanding therapeutic targets, drug development strategies, and translational biomedical research. Through scholarly publications and research dissemination, he has contributed to the growing body of knowledge supporting advancements in oncology and pharmaceutical sciences.[1]

Abstract

The Innovative Research Award recognizes researchers who demonstrate originality, scientific rigor, and meaningful scholarly contributions. Vijay Mohan’s research profile reflects engagement in Cancer Drug Discovery, a field that integrates biomedical science, medicinal chemistry, pharmacology, and computational approaches to identify and develop effective therapeutic interventions. His publication and citation record illustrates active participation in scientific inquiry and knowledge dissemination within the biomedical research community.[1][2]

Keywords

Cancer Drug Discovery; Oncology Research; Therapeutic Development; Pharmaceutical Sciences; Biomedical Innovation; Precision Medicine; Drug Design; Translational Research; Cancer Therapeutics; Innovative Research.

Introduction

Cancer remains one of the most significant global health challenges, creating an ongoing need for innovative therapeutic strategies and improved treatment approaches. Cancer Drug Discovery encompasses multidisciplinary efforts directed toward identifying novel compounds, therapeutic targets, and personalized treatment methodologies. Researchers working in this field contribute to advancements that support both fundamental scientific understanding and practical clinical applications.[2]

Research Profile

Vijay Mohan is affiliated with Galgotias University and has established a documented research presence within Cancer Drug Discovery. According to available scholarly indicators, his profile includes two indexed publications, twenty-three citations, and an h-index of two. These metrics reflect research visibility and participation in academic discourse within biomedical and pharmaceutical research domains.[1]

  • Research focus on cancer therapeutics and drug discovery.
  • Interest in translational and biomedical research methodologies.
  • Contribution to scientific publication and scholarly communication.
  • Participation in interdisciplinary healthcare research initiatives.

Research Contributions

Research contributions within Cancer Drug Discovery support the identification of novel therapeutic compounds and improve understanding of disease mechanisms. Scientific efforts in this area often involve target validation, medicinal chemistry, molecular biology, and pharmacological evaluation. Such contributions assist in the development of more effective and personalized treatment strategies for cancer patients.[2]

  • Investigation of therapeutic targets relevant to oncology.
  • Support for innovative approaches to drug development.
  • Contribution to evidence-based biomedical research.
  • Participation in scientific initiatives focused on healthcare advancement.

Publications

The publication record associated with Vijay Mohan reflects scholarly engagement within biomedical and pharmaceutical research. Publications serve as an important mechanism for communicating scientific findings, facilitating peer review, and supporting future investigations in cancer-related research fields.[1]

  1. Research publications related to cancer therapeutics.
  2. Scientific articles supporting drug discovery initiatives.
  3. Peer-reviewed contributions to biomedical literature.
  4. Collaborative research outputs within healthcare sciences.

Research Impact

Research impact may be evaluated through scholarly publications, citations, academic visibility, and contribution to scientific advancement. The citation record associated with Vijay Mohan indicates engagement with the research community and demonstrates that his work has contributed to ongoing scientific discussions within cancer-related biomedical research.[1]

Award Suitability

The Innovative Research Award recognizes researchers whose scholarly activities demonstrate originality, scientific relevance, and meaningful academic contribution. Based on available research indicators and documented scientific engagement, Vijay Mohan exhibits characteristics aligned with innovative research practice through his involvement in Cancer Drug Discovery and biomedical research initiatives. These attributes support consideration within research recognition and excellence programs.[1]

Conclusion

Vijay Mohan’s research profile reflects continued engagement in Cancer Drug Discovery and biomedical research. Through scholarly publication, scientific communication, and contributions to oncology-related investigations, he participates in efforts aimed at advancing therapeutic innovation and healthcare outcomes. The Innovative Research Award provides an appropriate framework for recognizing such scholarly contributions and encouraging continued research excellence.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Vijay Mohan, Author ID 57472028500. Scopus. https://www.scopus.com/authid/detail.uri?authorId=57472028500
  2. Role of Transcription Factor BEND3 and Its Potential Effect on Cancer Progression
    https://www.mdpi.com/2072-6694/15/14/3685

Mutthuraj Dasegowda | Cancer Biology, Oncology | Young Scientist Award

Published-on by Indian Scientist

Mr. Mutthuraj Dasegowda | Cancer Biology, Oncology | Young Scientist Award

JSS Academy of Higher Education and Research, India

Mr. Mutthuraj Dasegowda is a dedicated researcher in cancer biology and molecular sciences, currently pursuing doctoral studies focused on epigenetics and plant-based anticancer therapeutics. With a strong academic background in molecular biology, he has contributed to multidisciplinary research involving bioactive compounds and disease mechanisms. His experience includes research, teaching, and editorial roles, alongside active scientific collaborations. Recognized with academic awards and a research fellowship, his interests span natural products, cancer therapy, and immunology, reflecting a commitment to advancing innovative biomedical research.

Citation Metrics (Scopus)

10
8
6
4
0

Citations
2

Documents
6

h-index
1

Citations

Documents

h-index

Featured Publications

Ruby Anto | Cancer | Best Researcher Award

Published-on by Indian Scientist

Dr. Ruby Anto | Cancer | Best Researcher Award

Centre of Excellence in Nutraceuticals, Government of Kerala | India

Dr. Ruby John Anto is a distinguished biomedical scientist whose pioneering research has significantly advanced the field of cancer biology and nutraceutical sciences. She holds a Ph.D. in Biochemistry from Amala Cancer Research Centre, Thrissur, and has served in various scientific capacities at the Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, including Scientist G, before taking up her current role as Chief Scientist at the Centre of Excellence in Nutraceuticals under KSCSTE, Government of Kerala, and Honorary Scientist at the Institute of Advanced Virology. Her research focuses on the bioprospecting of natural compounds with therapeutic potential against cancer, inflammation, and lifestyle diseases. A highlight of her work is the discovery of Uttroside B, a potent anticancer compound that earned “Orphan Drug” designation from the US FDA for liver cancer treatment and is patented internationally. With an h-index of 42, i10-index of 63, and over 7,600 citations from 80+ international publications, Dr. Anto’s work has received widespread recognition. She has been honored with national and international awards, including the National Woman Bio-Scientist Award and the Keystone Symposia Global Health Award. Her scientific leadership continues to inspire innovation in cancer research, nutraceuticals, and translational medicine.

Profiles: Google Scholar | Scopus

Featured Publications

Ruby, A. J., Kuttan, G., Babu, K. D., Rajasekharan, K. N., & Kuttan, R. (1995). Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Letters, 94(1), 79–83. https://doi.org/ (Cited by: 1571)

Anto, R. J., Mukhopadhyay, A., Denning, K., & Aggarwal, B. B. (2002). Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: Its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis, 23(1), 143–150. https://doi.org/ (Cited by: 593)

Anto, R. J., Sukumaran, K., Kuttan, G., Rao, M. N. A., Subbaraju, V., & Kuttan, R. (1995). Anticancer and antioxidant activity of synthetic chalcones and related compounds. Cancer Letters, 97(1), 33–37. https://doi.org/ (Cited by: 456)

Oommen, S., Anto, R. J., Srinivas, G., & Karunagaran, D. (2004). Allicin (from garlic) induces caspase-mediated apoptosis in cancer cells. European Journal of Pharmacology, 485(1–3), 97–103. https://doi.org/ (Cited by: 393)

Anto, R. J., Mukhopadhyay, A., Shishodia, S., Gairola, C. G., & Aggarwal, B. B. (2002). Cigarette smoke condensate activates nuclear transcription factor-κB through phosphorylation and degradation of IκBα: Correlation with induction of cyclooxygenase-2. Carcinogenesis, 23(9), 1511–1518. https://doi.org/ (Cited by: 335)

Saroj Rajan | Oncology | Best Researcher Award

Published-on by Indian Scientist

Dr. Saroj Rajan | Oncology | Best Researcher Award

Sir Ganga Ram Hospital | India

Dr. Saroj Rajan is a distinguished medical professional specializing in Gynaecologic Oncology, with an impressive academic and clinical foundation in Obstetrics and Gynaecology. She holds an MBBS from Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, an MD in Obstetrics and Gynaecology from AIIMS, New Delhi, and an MCh in Gynaecologic Oncology from the same institute. Her professional journey includes positions at renowned institutions such as AIIMS New Delhi, Sir Ganga Ram Hospital, and Sri Balaji Medical College, along with an international fellowship at Charles University, Prague. Dr. Rajan’s research contributions span topics like nutritional assessment, cachexia, biomarkers, cancer surgery, and endometrial carcinoma, reflecting her dedication to improving outcomes in gynecologic cancer care. She has authored 8 scientific publications, accumulating 3 citations from 3 documents and an h-index of 1, indicating her growing influence in academic oncology. Recognized with prestigious awards including top honors at AGOI and AOGIN conferences, she also serves as an Editorial Fellow for Gynecologic Oncology Reports (Elsevier). Her research interest lies in gynecologic malignancies, cancer nutrition, and surgical innovation. Dr. Rajan continues to advance women’s health through evidence-based clinical practice and impactful research.

Profiles: Orcid | Scopus

Featured Publications

Singhal, S., Rajan, S., Khurana, S., Kumari, R., Meena, J., Singh, N., Singh, A., Jayraj, A., Pramanik, R., & Kumar, L. (2025). Reproductive outcomes following chemotherapy for gestational trophoblastic neoplasia: Experience from a tertiary care center. European Journal of Obstetrics & Gynecology and Reproductive Biology. https://doi.org/10.1016/j.ejogrb.2025.114774

Rajan, S., Rathore, R., Malhotra, N., Sharma, D. N., Khurana, S., Dhamija, E., Mathur, S., & Singhal, S. (2025). Vaginal clear cell carcinoma without diethylstilbestrol exposure: A rare case and review of 38 reported cases. Indian Journal of Gynecologic Oncology. https://doi.org/10.1007/s40944-025-01034-9

Rajan, S., Dhamija, E., Malhotra, N., Kaur, P., Yadav, R. K., Meena, J., Kumari, R., Singh, A., Singh, A., & Khurana, S. (2025). Nutritional assessment in gynecological cancers: Experience from an Indian tertiary care center. European Journal of Obstetrics & Gynecology and Reproductive Biology. https://doi.org/10.1016/j.ejogrb.2025.113964

Rajan, S., Dhamija, E., Malhotra, N., Vats, D., Singh, A., & Singhal, S. (2025). Cachexia in gynecologic cancers: The role of biomarkers and cachexia index. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.70262

Ray, M. D., Ray, C., & Rajan, S. (2025). “Pseudo cytoreductive surgery” in ovarian cancer: Disturbing insights from referral patterns to a leading oncology center in India. Journal of Gynecologic Surgery. https://doi.org/10.1089/gyn.2024.0004

Sandeep Pandey | Oncology | Best Researcher Award

Published-on by Indian Scientist

Dr. Sandeep Pandey | Oncology | Best Researcher Award

King George’s Medical University | India

Sandeep Pandey is a dedicated researcher in molecular cancer biology, currently pursuing a PhD in Biochemistry at King George’s Medical University, Lucknow. He works as a Senior Research Fellow in the Department of Biochemistry and Hemato-Pathology, focusing on the molecular mechanisms underlying leukemia. His academic journey reflects a deep interest in biochemistry, molecular biology, and cancer therapeutics. Alongside his research, he has contributed to teaching and mentoring students in biology and zoology. With multiple publications, conference presentations, and active involvement in professional societies, he continues to advance his expertise in molecular diagnostics and translational cancer research.

Professional Profile

Google Scholar

Education

Sandeep Pandey has built a strong academic foundation in life sciences through progressive studies in biochemistry and related disciplines. He earned his undergraduate degree in Chemistry, Zoology, and Botany, followed by a postgraduate degree in Biochemistry, where he conducted research on recombinant enzyme expression and purification. His academic training also included hands-on work in molecular biology laboratories, fostering expertise in protein studies and genetic techniques. Currently, he is pursuing doctoral research in Biochemistry at King George’s Medical University, focusing on cancer biology and molecular diagnostics. His educational background reflects a blend of theoretical understanding and practical laboratory experience.

Professional Experience

Sandeep Pandey has substantial experience in research, particularly in molecular cancer biology, with a focus on leukemia. He has served as a Junior and Senior Research Fellow at King George’s Medical University, working extensively on cell culture, gene expression analysis, and molecular diagnostic techniques. His professional journey also includes work as a Clinical Research Coordinator for a cancer drug trial, contributing to translational oncology studies. In addition, he has been a graduate trainee at a premier research institute, where he worked on molecular cloning and protein purification. His experience extends to part-time teaching, training students for academic and competitive examinations.

Awards and Recognition

Sandeep Pandey has received notable recognition for his academic and research contributions. He was awarded a Senior Research Fellowship by the Indian Council of Medical Research for his work on leukemia and qualified the GATE examination in life sciences. His research presentations at conferences have earned accolades, including a first prize for best oral presentation. He has been invited as a reviewer for reputed scientific journals and holds lifetime memberships in professional societies such as the Indian Society of Oncology and the Indian Science Congress. His achievements reflect a commitment to advancing scientific knowledge and contributing to the research community.

Research Skills

Sandeep Pandey possesses a diverse set of research skills covering cell culture, molecular biology, bioinformatics, and in vivo studies. His expertise includes maintaining and analyzing cell lines, performing flow cytometry, gene knockdown techniques, PCR, Western blotting, ELISA, and fluorescence microscopy. He is proficient in genomic and proteomic analysis, animal handling for research, and data interpretation using specialized software. His skills extend to both experimental design and execution, with an emphasis on cancer biology and diagnostics. Additionally, he has experience in collaborative, multidisciplinary research environments, integrating laboratory findings with clinical applications for better understanding and treatment of diseases.

Notable Publications

Regulation of hypoxia dependent reprogramming of cancer metabolism: Role of hif-1 and its potential therapeutic implications in leukemia
Author: S Pandey, R Singh, N Habib, RM Tripathi, R Kushwaha, AA Mahdi
Journal: Asian Pacific Journal of Cancer Prevention: APJCP 25 (4), 1121
Year: 2024
Citations: 5

Expression of CXCL8 (IL-8) in the pathogenesis of T-cell acute lymphoblastic leukemia patients
Author: S Pandey, R Singh, N Habib, V Singh, R Kushwaha, AK Tripathi, …
Journal: Cureus 15 (9)
Year: 2023
Citations: 4

Correlation between salivary cortisol levels and diurnal variation in spirometric parameters in apparently healthy adults
Author: T Mathur, YR Annepu, PDK Chaitanya, R Ranjan, DK Verma, N Verma, …
Journal: Cureus 16 (10)
Year: 2024
Citations: 2

Concerns for human health relating to methylmercury (MeHg) toxicity in aquatic environment: a systematic literature review
Author: RM Tripathi, S Pandey, AA Mahdi, M Serajuddin, K Singh, M Kaleem
Journal: Journal of Advanced Zoology
Year: 2023
Citations: 2

Osteoporosis, Its Pathophysiology and Effect of Nutraceuticals.
Author: Z Ara, S Pandey, S Pant, RM Tripathi, D Rastogi, S Waliullah
Journal: Indian Journal of Public Health Research & Development 14 (3)
Year: 2023
Citations: 1

Conclusion

Sandeep Pandey’s professional journey reflects a consistent dedication to research, academic growth, and knowledge dissemination in the fields of biochemistry and molecular cancer biology. His expertise spans laboratory techniques, clinical research, and academic teaching, enabling him to contribute to both fundamental and applied sciences. With numerous publications, conference presentations, and active participation in professional bodies, he continues to expand his scientific horizons. His work demonstrates a strong commitment to advancing cancer research, improving diagnostic tools, and exploring novel therapeutic approaches. Through his academic and professional efforts, he aims to contribute meaningfully to biomedical sciences and healthcare innovation.